This observation agrees with ALT cancer data: TP53 mutations are common in ALT cancers, Li-Fraumeni patient fibroblasts (congenital TP53 mutation) more readily immortalize via ALT4, and TP53 mutations are slightly predictive for the ALT telomere maintenance mechanism over telomerase40. Here, TP53 is linked to cancer.